Clinical Cardiology Alert – December 1, 2010
December 1, 2010
View Issues
-
Does Atorvastatin Have Anti-ischemic Effects?
Statins are a cornerstone of treatment for patients with coronary artery disease (CAD). Their powerful lipid-lowering and plaque-stabilization effects are well known, as is their ability to reduce myocardial infarction and death. -
Incidence of LV Thrombus After Anterior MI in the Modern Era
Dual anti-platelet therapy with aspirin and a thienopyridine, such as clopidogrel, is recommended after ST elevation myocardial infarction (MI). -
Complications of Device Generator Replacements
Implantable cardiac rhythm devices are being used in an increasing number of patients and, in addition, patients who receive them are living longer. -
Cardiac Resynchronization for Class IV Heart Failure
Although cardiac resynchronization therapy (CRT) is a class-I indication for the treatment of NYHA class III-IV patients with heart failure, few class-IV patients have been treated in the reported trials. -
Genetic Analysis of Sudden Death Victims and Their Relatives
In this paper, Van der Werf and colleagues from the University of Groningen report the diagnostic yield of comprehensive cardiologic and genetic examinations in surviving relatives of sudden, unexplained death victims and in victims of cardiac arrest where the event occurred between the age of 1 and 50 years. -
Mitral Valve Prolapse in Marfan Syndrome
The incidence and significance of mitral valve prolapse (MVP) in patients with Marfan syndrome is poorly understood. -
BNP in Pregnancy
Increases in cardiac volume in the non-pregnant state increase BNP, but little is known about pregnancy and BNP levels. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Tiotropium for uncontrolled asthma, sibutramine pulled from market, incidence and mortality data from WHI, FDA Actions.